City-based vaccine maker Biological E. Limited on Monday said the company was selected as a recipient of mRNA technology to produce COVID-19 vaccines from the World Health Organisation. A press release from BE Limited said the WHOís Advisory Committee on Vaccine Product Development (ACPDV) selected the firm after examining a number of proposals from India, as a recipient of mRNA (ribonucleic acid) technology from the global health bodyís technology transfer hub. Mahima Datla, Managing Director, BE Ltd said: "BE has been investing in mRNA technologies since last year. This new technology will definitely strengthen our resolve to develop and manufacture more vaccines in future. This partnership with WHO will enhance our ability to develop next generation mRNA vaccines that could be more suitable globally and expand the reach of vaccines availability worldwide.íí